Inhibitory and enhancing effects of IFN-gamma and IL-4 on SHIV(KU) replication in rhesus macaque macrophages: correlation between Th2 cytokines and productive infection in tissue macrophages during late-stage infection.
HIV-1 is dual-tropic for CD4+ T lymphocytes and macrophages, but virus production in the macrophages becomes manifest only during late-stage infection, after CD4+ T cell functions are lost, and when opportunistic pathogens begin to flourish. In this study, the SHIV/macaque model of HIV pathogenesis was used to assess the role of cytokines in regulating virus replication in the two cell types. We injected complete Freund's adjuvant (CFA) intradermally into SHIV(KU)-infected macaques, and infused Schistosoma mansoni eggs into the liver and lungs of others. Tissues examined from these animals demonstrated that macrophages induced by CFA did not support viral replication while those induced by S. mansoni eggs had evidence of productive infection. RT-PCR analysis showed that both Th1 (IL-2 and IFN-gamma) and Th2 cytokines (IL-4 and IL-10) were present in the CFA lesions but only the Th2 cytokines were found in the S. mansoni lesions. Follow-up studies in macaque cell cultures showed that whereas IFN-gamma caused enhancement of virus replication in CD4+ T cells, it curtailed viral replication in infected macrophages. In contrast, IL-4 enhanced viral replication in infected macrophages. These studies strongly suggest that cytokines regulate the sequential phases of HIV replication in CD4 T cells and macrophages.
Buch
S
S
Department of Microbiology, Immunology, and Molecular Genetics, Marion Merrell Dow Laboratory of Viral Pathogenesis, 5000 Wahl Hall East, Kansas City, KS 66160, USA. sbuch@kum.edu
Pinson
D
D
King
C L
CL
Raghavan
R
R
Hou
Y
Y
Li
Z
Z
Adany
I
I
Hicks
A
A
Villinger
F
F
Kumar
A
A
Narayan
O
O
D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism; D005620:Freund's Adjuvant / Q000494:pharmacology; D006099:Granuloma / Q000821:virology; D006678:HIV / Q000472:pathogenicity; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D007371:Interferon-gamma / Q000096:biosynthesis / Q000494:pharmacology*; D016753:Interleukin-10 / Q000096:biosynthesis; D007376:Interleukin-2 / Q000096:biosynthesis; D015847:Interleukin-4 / Q000096:biosynthesis / Q000494:pharmacology*; D007963:Leukocytes, Mononuclear / Q000378:metabolism; D008099:Liver / Q000469:parasitology; D008168:Lung / Q000469:parasitology; D008253:Macaca mulatta; D008264:Macrophages / Q000378:metabolism* / Q000821:virology*; D012313:RNA / Q000378:metabolism; D012194:RNA-Directed DNA Polymerase / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012550:Schistosoma mansoni / Q000472:pathogenicity; D016097:Simian Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D015302:Simian Immunodeficiency Virus / Q000378:metabolism*; D018418:Th2 Cells / Q000378:metabolism*; D013997:Time Factors; D014779:Virus Replication / Q000502:physiology
D007376:Interleukin-2; D016753:Interleukin-10; D015847:Interleukin-4; D012313:RNA; D007371:Interferon-gamma; D005620:Freund's Adjuvant; D012194:RNA-Directed DNA Polymerase